M. Gross

发表

Molecular basis of AMP deaminase deficiency in skeletal muscle.

T. Morisaki, H. Morisaki, D. Pongratz, 1992, Proceedings of the National Academy of Sciences of the United States of America.

The Genetic Basis of Myoadenylate Deaminase Deficiency in Man

M. Gross, 1993 .

Benzbromarone and fenofibrate are lipid lowering and uricosuric: a possible key to metabolic syndrome?

U. Gresser, B. Gathof, M. Gross, 1994, Advances in experimental medicine and biology.

Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency

M. Gross, 1997, Journal of Inherited Metabolic Disease.

Serum levels of glucose, insulin, and C-peptide during long-term D-ribose administration in man

N. Zöllner, M. Gross, 1991, Klinische Wochenschrift.

Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency

N. Zöllner, M. Gross, S. Reiter, 1989, Klinische Wochenschrift.

Myoadenylate deaminase deficiency: Successful symptomatic therapy by high dose oral administration of ribose

K. Gerbitz, D. Pongratz, T. Deufel, 1986, Klinische Wochenschrift.

Normal restriction pattern (Hind III) of the myoadenylate deaminase gene in enzyme deficient patients

T. Morisaki, D. Pongratz, E. Holmes, 1990, Klinische Wochenschrift.

Ergometer exercise in myoadenylate deaminase deficient patients

U. Gresser, M. Gross, 1993, The clinical investigator.

Molecular biology of AMP deaminase deficiency

M. Gross, 1994, Pharmacy World and Science.

Myoadenylate deaminase deficiency, hypertrophic cardiomyopathy and gigantism syndrome.

M. Marx, R. Bittner, M. Wimmer, 1997, Pediatric neurology.

A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population

H. Reichmann, H. Goebel, Hanns Lochmüller, 2002, Neuromuscular Disorders.

New method for detection of C34-T mutation in the AMPD1 gene causing myoadenylate deaminase deficiency.

M. Gross, 1994, Annals of the rheumatic diseases.

Effects of oral ribose on muscle metabolism during bicycle ergometer in patients with AMP-deaminase-deficiency.

U. Gresser, N. Zöllner, M. Gross, 1991, Advances in experimental medicine and biology.

Capillary electrophoresis for screening of adenylosuccinate lyase deficiency

B. Gathof, M. Gross, P. Kölle, 1995, Electrophoresis.

Effect of ribose on cardiac adenine nucleotides in a donor model for heart transplantation.

M. Wehling, U. Gresser, C. Müller, 1998, European journal of medical research.

Identification of new mutations in the adenylosuccinate lyase gene associated with impaired enzyme activity in lymphocytes and red blood cells.

C. Salerno, C. Crifó, B. Luckow, 1998, Biochimica et biophysica acta.

Ribose administration during exercise: Effects on substrates and products of energy metabolism in healthy subjects and a patient with myoadenylate deaminase deficiency

N. Zöllner, B. Kormann, M. Gross, 1991, Klinische Wochenschrift.

Genetic basis of adenylosuccinase deficiency in an Italian patient.

C. Salerno, B. Luckow, D. Verginelli, 1998, Advances in experimental medicine and biology.

Myoadenylate deaminase deficiency with severe rhabdomyolysis

D. Pongratz, M. Gross, D. Wagner, 1993, European Journal of Pediatrics.

The Genetic Basis of Myoadenylate Deaminase Deficiency is Heterogeneous

H. Reichmann, M. Gross, E. Rotzer, 1998 .

Clinical Aspects and Biochemical Basis of AMP Deaminase Deficiency: A Clinician’s Point of View

N. Zöllner, M. Gross, D. Wagner, 1993 .

Normal hypoxanthine and ammonia release from working muscle in partial HPRT deficiency.

U. Gresser, B. Gathof, M. Gross, 1994, Advances in experimental medicine and biology.